From

Institution

Field

Type

Journal / venue: Annals of Oncology ×

Open access only Cited by patents (Lens) Include non-Aachen papers (citing/cited)

Reset

Papers 225

Sort: Cited Newest Oldest Fwci Patents ⇩ CSV

Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
2021 Annals of Oncology article Medicine Sarcoma Diagnosis and Treatment Open access

Alessandro Gronchi, Aisha B Miah, Angelo Paolo Dei Tos, Nuno Abecassis, Jyoti Bajpai, Sebastian Bauer, +73 more

1,062

citations
Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2023 Annals of Oncology article Medicine Lung Cancer Treatments and Mutations Open access cited by 1 patent

Lizza E.L. Hendriks, Keith M. Kerr, Jessica Menis, Tony S.K. Mok, Ursula Nestle, Antonio Passaro, +6 more

854

citations
Endometrial cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2022 Annals of Oncology article Medicine Endometrial and Cervical Cancer Treatments Open access

Ana Oaknin, Tjalling Bosse, Carien L. Creutzberg, Gonzalo H. Giornelli, Philipp Harter, Florence Joly, +6 more

657

citations
Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2023 Annals of Oncology article Medicine Lung Cancer Treatments and Mutations Open access

Lizza E.L. Hendriks, Keith M. Kerr, Jessica Menis, Tony S.K. Mok, Ursula Nestle, Antonio Passaro, +6 more

618

citations
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
2021 Annals of Oncology article Medicine Gastrointestinal Tumor Research and Treatment Open access

Paolo Giovanni Casali, Jean‐Yves Blay, Nuno Abecassis, Jyoti Bajpai, Sebastian Bauer, Roberto Biagini, +67 more

603

citations
Bone sarcomas: ESMO–EURACAN–GENTURIS–ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up
2021 Annals of Oncology article Medicine Sarcoma Diagnosis and Treatment Open access

Sandra J. Strauss, Anna Maria Frezza, Nuno Abecassis, Jyoti Bajpai, Sebastian Bauer, Roberto Biagini, +74 more

481

citations
Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer
2022 Annals of Oncology article Medicine PARP inhibition in cancer therapy Open access cited by 1 patent

Charles E. Geyer, Judy Ellen Garber, Richard D. Gelber, Greg Yothers, L. Ross, Priya Rastogi, +90 more

473

citations
Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up
2020 Annals of Oncology article Medicine Cancer Treatment and Pharmacology Open access

Berit Jordan, Anita Margulies, Fátima Cardoso, Guido Cavaletti, Hege Sagstuen Haugnes, Patrick Jahn, +5 more

348

citations
First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743
2022 Annals of Oncology article Medicine Occupational and environmental lung diseases Open access

Solange Peters, Arnaud Scherpereel, Robin Cornelissen, Youssef Oulkhouir, Laurent Greillier, Kaplan Ma, +12 more

266

citations
Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo
2020 Annals of Oncology article Medicine Cancer Immunotherapy and Biomarkers Open access

Thomas Karn, Carsten Denkert, Karsten Ernst Weber, Uwe Holtrich, Claus Alexander Hanusch, Bruno Valentin Sinn, +17 more

242

citations
Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up☆
2021 Annals of Oncology article Medicine Occupational and environmental lung diseases Open access

Sanjay Popat, Corinne Faivre Finn, Nicolas M Girard, Andrew Gordon Nicholson, Anna K. Nowak, Isabelle Opitz, +2 more

235

citations
Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
2024 Annals of Oncology article Medicine Cutaneous Melanoma Detection and Management Open access

Teresa Maria Santos Amaral, Margaret Ottaviano, Ana Maria Arance, Christian U. Blank, Vanna Chiarion‐Sileni, Marco Donia, +22 more

203

citations
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network
2020 Annals of Oncology article Medicine Sarcoma Diagnosis and Treatment Open access

George D. Demetri, Cristina R. Antonescu, Bodil Bjerkehagen, Judith V.M.G. Bovée, Kjetil Boye, Matias Rodrigo Chacon, +42 more

148

citations
Survival update of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma in the OpACIN and OpACIN-neo trials
2023 Annals of Oncology article Medicine Cutaneous Melanoma Detection and Management Open access

Judith M. Versluis, Alexander Maxwell Menzies, Karolina Sikorska, Elisa A. Rozeman, Robyn P.M. Saw, Winan J. van Houdt, +17 more

135

citations
Neurological and vascular complications of primary and secondary brain tumours: EANO-ESMO Clinical Practice Guidelines for prophylaxis, diagnosis, treatment and follow-up
2020 Annals of Oncology article Medicine Glioma Diagnosis and Treatment Open access

Patrick A. Roth, Andrea Pace, Émilie Le Rhun, Michael Weller, Cihan Ay, Elisabeth Cohen-Jonathan Moyal, +11 more

95

citations
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors (GIST) from the EORTC Soft Tissue and Bone Sarcoma Group (STBSG), the Australasian Gastro-Intestinal Trials Group (AGITG), UNICANCER, French Sarcoma Group (FSG), Italian Sarcoma Group (ISG), and Spanish Group for Research on Sarcomas (GEIS)☆
2021 Annals of Oncology article Medicine Gastrointestinal Tumor Research and Treatment Open access

Paolo Giovanni Casali, Axel Le Cesne, Andrés Poveda Velasco, Dusan Kotasek, Piotr Lukasz Rutkowski, Peter Hohenberger, +15 more

75

citations
Adjuvant chemotherapy is superior to chemoradiation after D2 surgery for gastric cancer in the per-protocol analysis of the randomized CRITICS trial
2020 Annals of Oncology article Medicine Gastric Cancer Management and Outcomes Open access

Wobbe O. de Steur, Romy M. van Amelsfoort, H.H. Hartgrink, Hein Putter, Elma Meershoek‐Klein Kranenbarg, Nicole C.T. van Grieken, +13 more

69

citations
Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma
2021 Annals of Oncology article Medicine Cutaneous Melanoma Detection and Management Open access

Robert V. Rawson, Carolien Bierman, Serigne Lo, Elena Shklovskaya, Elisa A. Rozeman, Alexander Maxwell Menzies, +23 more

68

citations
LBA83 Neoadjuvant chemotherapy with FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy for borderline resectable and resectable pancreatic cancer (PREOPANC-2): A multicenter randomized controlled trial
2023 Annals of Oncology conference-abstract Medicine Pancreatic and Hepatic Oncology Research Open access

Bas Groot Koerkamp, Quisette P. Janssen, Jacob L. van Dam, Bert A. Bonsing, H. J. M. Bos, Koop P Bosscha, +14 more

59

citations
LBA75 Neoadjuvant chemoradiotherapy followed by surgery versus active surveillance for oesophageal cancer (SANO-trial): A phase-III stepped-wedge cluster randomised trial
2023 Annals of Oncology conference-abstract Medicine Esophageal Cancer Research and Treatment Open access

Berend J. van der Wilk, Ben M. Eyck, Bas P. L. Wijnhoven, Sjoerd M. Lagarde, Camiel Rosman, Bo Jan Noordman, +14 more

52

citations
Efficacy of TIL therapy in advanced cutaneous melanoma in the current immuno-oncology era: updated systematic review and meta-analysis
2024 Annals of Oncology review Medicine Cancer Immunotherapy and Biomarkers Open access

Silvia Martin Lluesma, Inge Marie Svane, Urania G. Dafni, Katerina Vervita, Dimitris Karlis, Georgia Dimopoulou, +4 more

45

citations
1321MO Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2 (ERBB2)-mutant (HER2m) metastatic non–small cell lung cancer (NSCLC) with and without brain metastases (BMs): Pooled analyses from DESTINY-Lung01 and DESTINY-Lung02
2023 Annals of Oncology article Medicine Lung Cancer Treatments and Mutations Open access

B.T. Li, David Planchard, Kōichi Goto, Egbert Frederik Smit, J. De Langen, Yasushi Goto, +13 more

39

citations
Antibody–drug conjugates in lung and breast cancer: current evidence and future directions—a position statement from the ETOP IBCSG Partners Foundation
2024 Annals of Oncology article Medicine Lung Cancer Treatments and Mutations Open access

Solange Peters, Sherene Loi, Fabrice André, Sarat Chandarlapaty, Enriqueta Felip, Stephen P. Finn, +9 more

37

citations
Peripheral T- and natural killer-cell lymphomas: ESMO–EHA Clinical Practice Guideline for diagnosis, treatment and follow-up
2025 Annals of Oncology article Medicine Lymphoma Diagnosis and Treatment Open access

Francesco d’Amore, Massimo Federico, Laurence de Leval, Fredrik Ellin, Olivier Hermine, Woo Seob Kim, +6 more

28

citations
LBA3 Pembrolizumab vs placebo plus weekly paclitaxel ± bevacizumab in platinum-resistant recurrent ovarian cancer: Results from the randomized double-blind phase III ENGOT-ov65/KEYNOTE-B96 study
2025 Annals of Oncology article Medicine Ovarian cancer diagnosis and treatment Open access

N. Colombo, E. Zsiros, Alexandra Sebastianelli, Mariusz Bidziński, Emad Matanes, K. Hasegawa, +12 more

26

citations